COSM Stock Overview
Manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cosmos Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.81 |
| 52 Week High | US$1.65 |
| 52 Week Low | US$0.47 |
| Beta | 3.14 |
| 11 Month Change | 4.30% |
| 3 Month Change | -26.36% |
| 1 Year Change | -20.59% |
| 33 Year Change | -99.10% |
| 5 Year Change | -98.75% |
| Change since IPO | -99.49% |
Recent News & Updates
Recent updates
Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump
Aug 16
Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch
Feb 23Cosmos Holdings intends to acquire telemedicine platform ZipDoctor
Sep 28Cosmos Holdings reports Q2 results
Aug 22Cosmos changes name to Cosmos Healthto
Jul 29Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically
Jul 20Cosmos Holdings to acquire bone health product portfolio from LIFE NLB
Jul 06Shareholder Returns
| COSM | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 12.5% | 4.1% | 2.0% |
| 1Y | -20.6% | 4.6% | 32.4% |
Return vs Industry: COSM underperformed the US Healthcare industry which returned 4.6% over the past year.
Return vs Market: COSM underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| COSM volatility | |
|---|---|
| COSM Average Weekly Movement | 10.7% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: COSM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: COSM's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 123 | Greg Siokas | www.cosmosholdingsinc.com |
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
Cosmos Health Inc. Fundamentals Summary
| COSM fundamental statistics | |
|---|---|
| Market cap | US$16.21m |
| Earnings (TTM) | -US$33.81m |
| Revenue (TTM) | US$56.04m |
0.3x
P/S Ratio-0.5x
P/E RatioIs COSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COSM income statement (TTM) | |
|---|---|
| Revenue | US$56.04m |
| Cost of Revenue | US$51.50m |
| Gross Profit | US$4.54m |
| Other Expenses | US$38.35m |
| Earnings | -US$33.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.64 |
| Gross Margin | 8.10% |
| Net Profit Margin | -60.34% |
| Debt/Equity Ratio | 29.4% |
How did COSM perform over the long term?
See historical performance and comparison